 This was a very widespread drug, and today it's something that is somewhat uniquely demonized. So I think that that's one key legacy of the growth of the pharmaceutical industry in this period, to really reinforce this divide in such a way that it's really difficult to have a conversation about psychoactive drugs, both licit and illicit, more broadly. And that's what I try to do in the book, to break down that divide a little bit.